Peter Neumann, Leader in Health Economics and Outcomes Research, Joins Precision Health Economics as Advisor
Peter Neumann, Leader in Health Economics and Outcomes Research, Joins Precision Health Economics as Advisor
Los Angeles, May 17, 2016 — Precision Health Economics (PHE), a global leader in health economic research, policy, and analytics, announced today that Peter Neumann, ScD has joined PHE in the role of principal scientific advisor.
Commentary: The Utility of Cancer Value Frameworks for Patients, Payers
Precision’s Chandra and Shafrin Address Value Frameworks in JAMA
After ACT Oncology Buy, Precision Medicine Snaps Up Applied Immunology – FierceBioTech
Fierce Biotech’s Ben Adams focuses on Precision’s acquisition of Applied Immunology.
Precision for Medicine Acquires Applied Immunology
Establishes Bay Area Immune-Response Laboratory Capability
Bethesda, Md. and Redwood City, Calif., May 3, 2016 – Precision for Medicine, part of the Precision Medicine Group, announced today that it has acquired Applied Immunology, an established expert in the creation and delivery of custom cell-based and immunoassay solutions. Applied Immunology supports innovative and targeted therapeutics developers across all areas, ranging from immuno-oncology to rare diseases to biosimilars from research to post-approval. Applied Immunology’s client base includes some of the most pioneering new venture-backed startups, along with many major global pharmaceutical firms.
Precision for Medicine acquires Applied Immunology – The pharmaletter
Chad Clark is quoted in the pharmaletter regarding the recent acquisition of Applied Immunology.